141 related articles for article (PubMed ID: 7530135)
41. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
[TBL] [Abstract][Full Text] [Related]
42. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
[No Abstract] [Full Text] [Related]
43. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Andersson B; Khouri I; Giralt S; Rios MB; Champlin R; Hester J; Deisseroth AB
Bone Marrow Transplant; 1994 Jul; 14(1):57-61. PubMed ID: 7951120
[TBL] [Abstract][Full Text] [Related]
44. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
[TBL] [Abstract][Full Text] [Related]
45. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
[TBL] [Abstract][Full Text] [Related]
46. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
[TBL] [Abstract][Full Text] [Related]
47. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
[TBL] [Abstract][Full Text] [Related]
48. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
[TBL] [Abstract][Full Text] [Related]
49. In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia.
Carella AM; Dejana A; Lerma E; Podestà M; Benvenuto F; Chimirri F; Parodi C; Sessarego M; Prencipe E; Frassoni F
Br J Haematol; 1996 Oct; 95(1):127-30. PubMed ID: 8857949
[TBL] [Abstract][Full Text] [Related]
50. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.
Singhal S; Mehta J; Desikan K; Siegel D; Singh J; Munshi N; Spoon D; Anaissie E; Ayers D; Barlogie B
Bone Marrow Transplant; 1999 Jul; 24(1):13-7. PubMed ID: 10435728
[TBL] [Abstract][Full Text] [Related]
51. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[TBL] [Abstract][Full Text] [Related]
52. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
53. Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial.
Copland M; Slade D; McIlroy G; Horne G; Byrne JL; Rothwell K; Brock K; De Lavallade H; Craddock C; Clark RE; Smith ML; Fletcher R; Bishop R; Milojkovic D; Yap C
Lancet Haematol; 2022 Feb; 9(2):e121-e132. PubMed ID: 34906334
[TBL] [Abstract][Full Text] [Related]
54. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
55. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
56. Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis.
Podestà M; Piaggio G; Sessarego M; Pitto A; Figari O; Soracco M; Carella AM; Dejana A; Rosti V; Fugazza G; Ravera G; Lerma E; Cazzola M; Bacigalupo A; Frassoni F
Exp Hematol; 2000 Feb; 28(2):210-5. PubMed ID: 10706077
[TBL] [Abstract][Full Text] [Related]
57. Collection of Philadelphia-negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia. Northern Regional Haematology Group.
Lennard A; Storey N; Dickinson AM; Irving JA; Rowe D; Conn JS; Proctor SJ
Leukemia; 1998 May; 12(5):746-52. PubMed ID: 9593273
[TBL] [Abstract][Full Text] [Related]
58. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
[TBL] [Abstract][Full Text] [Related]
59. Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia.
Carella AM; Pollicardo N; Pungolino E; Raffo MR; Podesta M; Ferrero R; Pierluigi D; Nati S; Naibo K; Congiu A
Leuk Lymphoma; 1993 Apr; 9(6):477-83. PubMed ID: 8101754
[TBL] [Abstract][Full Text] [Related]
60. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon.
Reiffers J; Taylor K; Gluckman E; Gorin NC; Mahon FX; Micléa JM; Destrée D; Gautier L
Br J Haematol; 1998 Aug; 102(3):639-46. PubMed ID: 9722288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
